DUSP5 and urinary bladder cancer: Therefore, compound 27 effectively negatively regulates the p38 MAPK signaling pathway by stably binding to DUSP5 and promotes apoptosis by upregulating the expression levels of DUSP5, thereby inhibiting the occurrence and development of bladder cancer.